Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
New Quest Alzheimer’s blood test can help clinical trial sponsors identify patients easily
The tests could prove useful in screening patients that coud benefit from therapies being tested for Alzheimer's. But uptake will depend, in part, on reimbursement, according to doctors surveyed by Quest.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Two announcements involving Walmart show its goal to provide convenience to employees/shoppers
Walmart's partnership with Health at Scale is meant to connect employees and their families with health providers who can best care for them. The retail giant's collaboration with Quest Diagnostics is aimed at increasing consumer access to high-quality lab tests.
As at-home Covid-19 testing rose, so did demand for other tests
After insurers were mandated to cover at-home Covid-19 tests, more people tested at-home screenings for other conditions, speakers said in a discussion hosted by MedCity INVEST. As preventive tests declined significantly during the pandemic, insurers also turned to creative means to give people access.
IQVIA pays Quest Diagnostics $760M to get full control of central lab joint venture
IQVIA has acquired Quest Diagnostics’ minority stake in Q2 Solutions, a central laboratory services joint venture the two companies formed in 2015. But Quest will remain a preferred provider of lab testing services under an agreement with Q2.
How have these firms making Covid-19 news fared as stock markets have tanked?
While all these companies have been involved in developing testing, vaccines and drugs for SARS-CoV-2, fears related to the global coronavirus pandemic have taken their toll on them as well as firms in other sectors.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Quest Diagnostics to start coronavirus testing Monday
The lab testing company made the announcement as the virus has rapidly spread across the world, and the administration's response has received widespread criticism. LabCorp also announced the availability of its test.
Quest Diagnostics acquires Blueprint Genetics
The companies said the deal, financial terms of which were not disclosed, would enable expansion of next-generation sequencing capabilities in rare diseases.
AMCA data breach potentially hits an additional 7.7M LabCorp customers
AMCA has told LabCorp that it is in the process of sending notices to the approximately 200,000 of the company's consumers whose credit card or bank account information may have been accessed and will offer them identity protection and credit monitoring services for 24 months.
Quest Diagnostics breach could potentially affect nearly 12 million individuals
Quest Diagnostics was notified by collections company vendor American Medical Collection Agency that an unauthorized user had access had access to AMCA’s system between August 1, 2018 and March 30, 2019.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Microsoft pushes forward on healthcare communication and data capabilities
The new tools build on the company's Azure cloud platform and allow more efficient and secure communication and sharing of personal health information.
Aetna and Ascension join blockchain pilot project for better provider directories
Keeping health plan provider directories current is a major administrative and cost burden for the industry, with an estimated $2.1 billion spent annually across the healthcare system to acquire and maintain provider data.
Humana, UnitedHealthcare, Quest Diagnostics and others launch blockchain initiative focused on provider data (Updated)
Five healthcare organizations — Humana, UnitedHealthcare, Optum, Quest Diagnostics and MultiPlan — have unveiled a blockchain-based effort that aims to make it easier to share provider directory data.
Quest Diagnostics’ Cleveland HeartLab acquisition reflects personalized medicine trend
In addition to the acquisition, Quest Diagnostics and the Cleveland Clinic have embarked on a strategic collaboration that will evaluate biomarkers for various diseases, with Quest developing tests for some of them.
Survey: 43 percent of physicians say they have the needed tools to succeed under value-based care
What does the future of value-based care look like, and how does technology tie in? A new survey from Quest Diagnostics and Inovalon takes a closer look.